[Public financing for off-label use of drugs].


Off-label use of drugs is common in all areas of medicine, but is specifically prevalent in pediatrics, oncology and in treating rare diseases. Such use may benefit patients, but on the other hand, there is concern about the safety aspects of these treatments. Besides the legal, ethical and safety issues associated with off-label use, arises the issue of… (More)


Cite this paper

@article{Hammerman2011PublicFF, title={[Public financing for off-label use of drugs].}, author={Ariel Hammerman and Yoel Lipschitz and Joseph S. Pliskin and Dan Greenberg}, journal={Harefuah}, year={2011}, volume={150 2}, pages={163-7, 204} }